The NK-activating receptor natural killer group 2 member D (NKG2D) is important for tumor rejection by human NK cells after binding its tumor-associated ligand, major histocompatibility complex class I-related chain A (MICA), which is expressed on the human bladder tumor cell surface. The gene discussed is KLRK1; the disease is urinary bladder neoplasm.